Skip to main content
. 2020 Sep-Oct;36(6):1220–1227. doi: 10.12669/pjms.36.6.2093

Table-II.

Comparison of clinical signs between SLE-MS group and SLE-nMS group [n(%)].

Variables SLE-MS SLE-nMS χ2 P
Lupus nephritis Yes 184(54.76) 334(37.03) 31.635 <0.001
No 152(45.24) 568(62.97)
Arthritis Yes 122(36.3) 417(46.2) 9.802 0.002
No 214(63.7) 485(53.8)
Rash Yes 167(49.7) 408(45.2) 1.966 0.161
No 169(50.3) 494(54.8)
Hair loss Yes 33(9.8) 123(13.6) 3.235 0.072
No 303(90.2) 779(86.4)
Proteinuria Yes 237 (70.5) 492(54.5) 25.854 <0.001
No 99(29.5) 410(45.5)
Oral ulcer Yes 47(14.0) 87(9.6) 4.783 0.029
No 289(86.0) 815(90.4)
Fever Yes 109(32.4) 331(36.7) 1.935 0.164
No 227(67.6) 571(63.3)
Thrombocytopenia Yes 122(36.3) 282(31.3) 2.835 0.092
No 214(63.7) 620(68.7)
Leukopenia Yes 239(71.1) 628(69.6) 0.265 0.607
No 97(28.9) 274(30.4)
Headache Yes 13(3.9) 30(3.3) 0.215 0.643
No 323(96.1) 872(96.7)
Epilepsy Yes 3(0.9) 3(0.3) - 0.353 *
No 333(99.1) 899(99.7)
Brain syndrome Yes 4(1.2) 5(0.6) - 0.264 *
No 332(98.8) 897(99.4)
Mental illness Yes 6(1.8) 10(1.1) - 0.396 *
No 330(98.2) 892(98.9)
Optic neuritis Yes 1(0.3) 0(0) - 0.217 *
No 335(99.7) 902(100)
Cerebral neuritis Yes 0(0) 5(0.56) - 0.332 *
No 336(100) 897(99.4)
Cerebrovascular disease Yes 1(0.3) 0(0) - 0.271 *
No 335(99.7) 902(100)
Vasculitis Yes 1(0.3) 1(0.1) - 0.469 *
No 335(99.7) 901(99.9)
Tubular urine Yes 37(11.0) 44(4.9) 15.063 <0.001
No 299(89.0) 858(95.1)
Hematuria Yes 126(37.5) 251(27.8) 10.815 0.001
No 210(62.5) 651(72.2)

Note: Significant results are highlighted in bold type.

*

indicates the P value obtained by Fisher’s exact test.